PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 8.163
EU - Europa 3.476
AS - Asia 998
SA - Sud America 16
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.681
Nazione #
US - Stati Uniti d'America 8.055
IT - Italia 771
DE - Germania 657
CN - Cina 612
IE - Irlanda 510
SE - Svezia 497
UA - Ucraina 290
HK - Hong Kong 180
AT - Austria 179
GB - Regno Unito 168
CA - Canada 102
FR - Francia 101
RU - Federazione Russa 85
FI - Finlandia 78
VN - Vietnam 64
DK - Danimarca 63
IN - India 46
TR - Turchia 42
NL - Olanda 26
JP - Giappone 23
ES - Italia 17
BE - Belgio 14
SG - Singapore 10
AU - Australia 7
CH - Svizzera 7
IR - Iran 6
BR - Brasile 5
EU - Europa 5
KR - Corea 5
SA - Arabia Saudita 5
CL - Cile 4
MX - Messico 4
CO - Colombia 3
EG - Egitto 3
PE - Perù 3
PL - Polonia 3
RO - Romania 3
SC - Seychelles 3
BG - Bulgaria 2
HR - Croazia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BT - Bhutan 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
TW - Taiwan 1
Totale 12.681
Città #
Ann Arbor 2.328
Woodbridge 670
Fairfield 669
Chandler 562
Dublin 493
Houston 475
Wilmington 463
Ashburn 443
Frankfurt am Main 437
Jacksonville 297
Seattle 290
Dearborn 261
New York 231
Cambridge 222
Princeton 194
Hong Kong 178
Vienna 178
Milan 171
Nanjing 139
Lawrence 92
Altamura 91
Beijing 68
San Diego 53
Dong Ket 48
Lachine 43
Nanchang 42
Shanghai 39
Falls Church 37
Guangzhou 36
Lissone 32
Andover 31
Boardman 30
Shenyang 30
Jinan 29
Tianjin 27
Helsinki 24
Pune 24
Ottawa 23
London 22
Hebei 20
Zhengzhou 19
Changsha 18
Ningbo 18
Kunming 16
Norwalk 16
Toronto 16
Fremont 15
Hangzhou 15
Jiaxing 15
Rome 15
Brussels 14
Huizen 13
Redmond 13
Edmonton 12
Kocaeli 12
Auburn Hills 11
Monza 10
Kiev 9
Singapore 9
Mountain View 8
Nürnberg 8
San Mateo 8
Taizhou 8
Hefei 7
Leawood 7
Paullo 7
Washington 7
Detroit 6
Duncan 6
Kilburn 6
Montréal 6
Saint Louis 6
Bari 5
Chicago 5
Los Angeles 5
Pavia 5
Taiyuan 5
University Park 5
Wuhan 5
Abbiategrasso 4
Bologna 4
Cernusco sul Naviglio 4
Changchun 4
Chengdu 4
Daejeon 4
Genoa 4
Lanzhou 4
Levate 4
Madrid 4
Melbourne 4
Naples 4
Simi Valley 4
Soresina 4
São Paulo 4
Tokyo 4
Brugherio 3
Buccinasco 3
Catania 3
Concepción 3
Dallas 3
Totale 10.012
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 320
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 319
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 298
MALDI imaging in Fabry nephropathy: a multicenter study 288
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 261
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 251
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 246
Microscopic Polyangiitis 245
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 226
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 223
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 218
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 208
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 208
Kidney Involvement 208
The putative role of MALDI-MSI in the study of Membranous Nephropathy 206
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 195
Proteomics for the study of new biomarkers in Fabry disease: State of the art 194
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 182
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 176
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 174
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 172
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 167
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 167
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 165
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 164
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 157
Parapelvic cysts, a distinguishing feature of renal Fabry disease 157
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 156
Obesity-associated hypertension in childhood: A new epidemic problem 155
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 154
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 154
Role of fat distribution indicators in the identification of hypertension in children 153
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 151
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 144
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 144
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 143
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 143
Usefulness of waist circumference for the identification of childhood hypertension 142
Renal afferents signaling diuretic activity in the cat 140
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 139
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 136
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 133
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 132
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 127
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 127
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 126
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 126
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 125
ANCA-associated vasculitis in childhood: Recent advances 125
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 123
Anticoagulant-related nephropathy: a pathological note 121
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 118
Hypertension in childhood: autonomic and metabolic patterns 117
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 117
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 116
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 115
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 115
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 113
Redefining the pulvinar sign in fabry disease 109
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 108
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 107
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 107
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 105
Avacopan for the treatment of ANCA-associated vasculitis 105
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 101
Analysis of heart period and arterial pressure variability in childhood hypertension: key role of baroreflex impairment 100
Sympathetic activation in cardiovascular and renal disease 98
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 98
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 98
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 97
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 96
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 95
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 94
[Clinical and histological findings in Fabry nephropathy] 93
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 89
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 88
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 88
Tumour incidence in Fabry disease: A cross-sectional study 85
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 84
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 82
La diagnosi precoce di malattia 78
La terapia enzimatica sostitutiva nella malattia di Fabry 76
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 75
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 73
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 73
Cardiological follow-up in patients with Fabry disease 68
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 67
Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management [Il coinvolgimento cardiaco nella malattia di Anderson-Fabry: Nuove raccomandazioni sulla diagnosi, il follow-up e la terapia] 63
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 62
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 62
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 60
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience 59
Renal reflexes and denervation in heart failure 54
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 51
The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts 43
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5) 41
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 28
Migalastat treatment in a kidney-transplanted patient with fabry disease and n215s mutation: The first case report 27
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 22
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 21
Totale 13.155
Categoria #
all - tutte 38.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019631 0 0 0 0 0 0 0 0 0 101 223 307
2019/20202.176 275 131 173 167 185 275 303 162 205 114 147 39
2020/20212.474 126 79 210 228 211 251 278 308 218 215 148 202
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.418 56 46 53 81 191 506 288 56 119 22 0 0
Totale 13.212